7 completed, 2 terminated, 1 recruiting. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 7, Terminated 2, Recruiting 1 |
Follow Guerbet: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease gadopiclenol, Gadoterate meglumine (Dotarem) - Steno-occlusive Disease | Phase 3 | Recruiting | Guerbet | 315 | 2026-07-28 | 2026-10-07 |
| Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas Elucirem, Dotarem - Brain Tumor, Primary, Brain Tumor, Recurrent | Phase 3 | Completed | Guerbet | 138 | 2023-09-07 | 2026-01-29 |
| Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children Gadopiclenol, Comparator (gadobutrol) - Lesion in Body Region, CNS Lesion | Phase 3 | Completed | Guerbet | 240 | 2023-07-21 | 2026-06-25 |
| Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) gadopiclenol, Gadobutrol 1 MMOLE/ML Intravenous Solution - Lesion in Body Region | Phase 3 | Completed | Guerbet | 324 | 2019-08-27 | 2025-10-27 |
| Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) gadopiclenol, Gadobutrol 1Mmol/mL Solution for Injection Vial - CNS Lesion, Blood Brain Barrier Defect | Phase 3 | Completed | Guerbet | 260 | 2019-06-03 | 2025-09-22 |
| Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions Dotarem (gadoterate meglumine), Magnevist (gadopentetate dimeglumine) - Diagnostic Self Evaluation, Central Nervous System Diseases | Phase 3 | Completed | Guerbet | 416 | 2010-09-01 | 2019-04-18 |
| Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Dotarem, TOF MRA - Cerebral Arterial Diseases | Phase 3 | Completed | Guerbet | 222 | 2009-10-01 | 2016-06-16 |
| Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Dotarem, TOF MRA - Cerebral Arterial Diseases | Phase 3 | Completed | Guerbet | 211 | 2009-10-01 | 2016-06-16 |
| Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF) Dotarem, Time of Flight - Renal Disease | Phase 3 | Terminated | Guerbet | 13 | 2009-09-01 | 2016-05-26 |
| Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Gadoterate meglumine (Dotarem), Time of Flight Magnetic Resonance Angiography - Renal Artery Stenosis | Phase 3 | Terminated | Guerbet | 33 | 2009-04-01 | 2016-05-20 |
Cerebral Arterial Diseases (2) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Kidney Diseases (1) · Renal Artery Obstruction (1)
gadoterate meglumine (7) · gadopiclenol (5) · gadobutrol (2) · Gadolinium DTPA (1) · Solutions (1)
United States (8) · Italy (5) · France (4) · Germany (4) · Hungary (4) · Poland (4) · South Korea (4) · Spain (4) · Mexico (2) · Argentina (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1)
Frantz Hebert (1) · Ken Maravilla, MD (1) · Lorie Loevner, MD (1) · Toshiaki Taoka, MD (1)